UNITY: A low-field magnetic resonance neuroimaging initiative to characterize neurodevelopment in low and middle-income settings

Autor: F. Abate, A. Adu-Amankwah, KA Ae-Ngibise, F Agbokey, VA Agyemang, CT Agyemang, C. Akgun, J. Ametepe, T. Arichi, KP Asante, S. Balaji, L. Baljer, PJ Basser, J. Beauchemin, C. Bennallick, Y. Berhane, Y. Boateng-Mensah, NJ Bourke, L. Bradford, MMK Bruchhage, R.Cano Lorente, P. Cawley, M. Cercignani, V. D Sa, A.de Canha, N.de Navarro, DC Dean, III, J. Delarosa, KA Donald, A. Dvorak, AD Edwards, D. Field, H. Frail, B. Freeman, T. George, J. Gholam, J. Guerrero-Gonzalez, JV Hajnal, R. Haque, W. Hollander, Z. Hoodbhoy, M. Huentelman, SK Jafri, DK Jones, F. Joubert, T. Karaulanov, MP Kasaro, S. Knackstedt, S. Kolind, B. Koshy, R. Kravitz, S.Lecurieux Lafayette, AC Lee, B. Lena, N. Lepore, M. Linguraru, E. Ljungberg, Z. Lockart, E. Loth, P. Mannam, KM Masemola, R. Moran, D. Murphy, FL Nakwa, V. Nankabirwa, CA Nelson, K. North, S. Nyame, R. O Halloran, J. O'Muircheartaigh, BF Oakley, H. Odendaal, CM Ongeti, D. Onyango, SA Oppong, F. Padormo, D. Parvez, T. Paus, MS Pepper, KS Phiri, M. Poorman, JE Ringshaw, J. Rogers, M. Rutherford, H. Sabir, L. Sacolick, M. Seal, ML Sekoli, T. Shama, K. Siddiqui, N. Sindano, MB Spelke, PE Springer, FE Suleman, PC Sundgren, R. Teixeira, W. Terekegn, M. Traughber, MG Tuuli, J.van Rensburg, F. Váša, S. Velaphi, P. Velasco, IM Viljoen, M. Vokhiwa, A. Webb, C. Weiant, N. Wiley, P. Wintermark, K. Yibetal, SCL Deoni, SCR Williams

Publikováno v: Developmental Cognitive Neuroscience, Vol 69, Iss , Pp 101397- (2024)

Measures of physical growth, such as weight and height have long been the predominant outcomes for monitoring child health and evaluating interventional outcomes in public health studies, including those that may impact neurodevelopment. While physic

Externí odkaz: https://doaj.org/article/c765e19e6dd449daa75f336a3cfcd19c

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Autor: Vivek Subbiah, Linghua Wang, Sara Ahmed, Michael Frumovitz, Jing Gong, Chantale Bernatchez, Siqing Fu, Aung Naing, Funda Meric-Bernstam, Shubham Pant, Nizar Tannir, Renata Ferrarotto, Joud Hajjar, Shi-Ming Tu, Mingxuan Xu, Anas Alshawa, Bettzy Stephen, Matthew Campbell, David S Hong, Sarina A Piha-Paul, Jordi Rodon Ahnert, Apostolia M Tsimberidou, Daniel D Karp, Timothy A Yap, Rivka R Colen, Vinod Ravi, Camilo Jimenez, Kanwal P Raghav, Gauri R Varadhachary, Ecaterina E Ileana Dumbrava, Sarjeel H Sabir, Saria Khan, Jeane M Painter, Abulrahman Abonofal, Richard M Simon

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)

Background Patients with advanced rare cancers have poor prognosis and few treatment options. As immunotherapy is effective across multiple cancer types, we aimed to assess pembrolizumab (programmed cell death 1 (PD-1) inhibitor) in patients with adv

Externí odkaz: https://doaj.org/article/633cee93179a43e799cae34404daa006

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Autosomal recessive EXT2 syndrome - extending the phenotypic spectrum of an emerging condition, a further case?

Autor: Ataf H, Sabir, Juhi, Singhal, Jessica, Man, Nicola, Cooper, Moira, Cheung, Melita, Irving

Publikováno v: Clinical Dysmorphology. 31:84-90

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b06301ee55157bcbafdeb521dc886257
https://doi.org/10.1097/mcd.0000000000000406